EU Business Round-Up: Sanofi Pens Enzymatica Deal, Germany's WindStar Acquired, Ipsen's Sales Slump
Latest EU company news: Sanofi grows OTC portfolio in France and Italy with ColdZyme; Germany's WindStar Medical gets UK owners; and France's Ipsen continues to fell effects of COVID-19 on sales.
You may also be interested in...
Ipsen CEO David Loew has kicked off a strategic review of the company's "non core" Consumer Healthcare business, which has endured a particularly tough year thanks to the COVID-19 pandemic.
With FSA set to publish its public register detailing which CBD supplements can lawfully remain on the UK market, what can companies do if their product doesn't make the list? Barrister Jonathan Kirk QC set out the limited options left open to firms during a recent webinar.
The latest European consumer health business news: France's Mayoly Spindler acquires Italian supplements specialist Biohealth; UK-based Flarin gets funding to expand at home and abroad; and Sweden's Karo plots further M&A in 2021.